1. Volume 68, Issue 1, Pages 154-160 (July 2015)
Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma 
Roberto Iacovelli, Francesco Massari, Laurence Albiges, Yohann Loriot, Christophe Massard, Karim Fizazi, Bernard Escudier 
European Urology 
Volume 68, Issue 1, Pages (July 2015)
DOI: /j.eururo
Copyright © 2014 European Association of Urology Terms and Conditions

2. Fig. 1
Tumor flare in patients according to the reason for discontinuation of tyrosine kinase inhibitor therapy. GR1=growth rate before discontinuation; GR2=growth rate after discontinuation.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions

3. Fig. 2
Overall survival (OS0) based on median values of (A) growth rate before discontinuation (GR1) and (B) growth rate after discontinuation (GR2) of tyrosine kinase inhibitor therapy.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions